GSK3B and schizophrenia: The present study explored the in vivo effects of one-week oral administration of aripiprazole on the GSK3β-dependent signalling pathways in three brain regions that are associated with schizophrenia and the actions of antipsychotics, in comparison with haloperidol and bifeprunox.